Triple-negative breast cancer (TNBC) is an aggressive breast cancer. It spreads quickly and has few treatment options. It is ...

第 47 届圣安东尼奥乳腺癌研讨会（SABCS）于 2024 年 12 月 10 日至 13 日顺利举行。在全体大会环节，由复旦大学附属肿瘤医院邵志敏教授牵头的一项「卡瑞利珠单抗联合化疗新辅助治疗早期或局部晚期三阴性乳腺癌的 CamRelief 研究 ...

SAN ANTONIO -- A first-in-kind trial of molecular residual disease (MRD)-guided therapy in breast cancer came to an early end ...

Triple-negative breast cancer (TNBC) remains one of the most aggressive types of breast cancer.  Determined by a lack of ...

A Chinese research team has developed a new treatment with the potential to significantly improve survival rates for a ...

In this randomized controlled trial, among patients with early-stage triple-negative breast cancer (TNBC), the addition of ...

The addition of atezolizumab to neoadjuvant chemotherapy failed to significantly improve event-free survival in patients with ...

Olaparib Demonstrates Survival Benefit in Early Breast Cancer: Data from the phase 3 OlympiA trial (NCT02032823) showed that ...